To include your compound in the COVID-19 Resource Center, submit it here.

CEPH beats Street, ups guidance

Cephalon (CEPH) after market close Wednesday reported third quarter EPS of $0.35, or $0.07 better than the Street consensus of $0.28. Product sales increased 65%

Read the full 250 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE